TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05898646

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Echocardiography
Description: Undergo echocardiography

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Echocardiography
Description: Undergo echocardiography

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: X-Ray Imaging
Description: Undergo x-ray imaging
Study: NCT04609280

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intensity modulated radiotherapy (IMRT)/volumetric modulated arc therapy (VMAT) or Pencil beam proton therapy (PBPT)
Description: Delivered over 6 weeks in 30 daily fractions in the adjuvant setting and over 6.5 weeks in 33 daily fractions in the definitive setting. In the adjuvant setting, areas with positive surgical margins or nodal stations with pathologic extranodal extension will receive 63 Gy. Margin negative resection bed and involved nodal stations without extranodal extension will receive 54 Gy. Low-risk elective nodal volumes (i.e. ceCTV) will receive 51 Gy. In the definitive setting, gross disease will receive 69.96 Gy, areas at high-risk for subclinical disease will receive 60 Gy, and areas at low-risk for harboring subclinical disease (i.e. ceCTV) will receive 52.8 Gy.
Study: NCT05697679

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Treatment group
Description: WeChat groups will be set up, and once a week on Monday, articles on physical exercise and once a week on Wednesday, 3-minute films about health education will be shared. For the duration of the 3-month intervention period, the following technologies will be used to deliver the GAT-pap: (1) Short Messaging Service (SMS) text (batch messaging); (2) WeChat (e.g., physical activity guidelines, group chats); and (3) monthly face-to-face interviews (behaviour change promotion, risk factor management). Although not essential, participants will be urged to register their daily exercise in the group chat. In order to determine if they are accomplishing their goals and what objectives they should be pursuing, the researchers will develop customised training regimens for each participant.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Contral group
Description: One or two times each week, participants in the control group will get general lifestyle advice through SMS. They will not participate in the intervention's fitness routines, online classes, group chats, or films with health educators. Individual workout regimens, goals, or comments are not given by researchers. Participants in the control group's complaints or questions will always be answered with basic health information and suggestions. Researchers won't ask for individual advice or comments from other professionals.
Study: NCT05436028

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcatheter Tricuspid Valve Intervention
Description: Due to unsustainable effect of medical therapy and high risks of surgical treatment, transcatheter tricuspid valve intervention (TTVI) has been a major field of study in the world in the last 10 years. TTVI could potentially reduce TR with lower periprocedural risk and improve the patient's clinical status and prognosis. Per the ESC guidelines for surgical and interventional treatment of tricuspid regurgitation (2021 ESC/EACTS Guidelines for the Management of Valvular Heart Disease), Transcatheter intervention for symptomatic secondary severe TR may be considered in inoperable patients at a Heart Valve Centre with expertise in the treatment of tricuspid valve disease (Class IIb).~Transcatheter tricuspid treatment options can be divided into categories based on their mechanism of action: coaptation enhancement (edge-to-edge repair and spacer device), annuloplasty devices, caval valve implantation and valve replacement.
Study: NCT05893563

Intervention type: OTHER
Intervention: Standard Post-Operative Clinic Visit
Description: In clinic, the joint will be assessed (ROM, stability testing), standard X-rays will be taken of the joint, and patient reported outcomes (questionnaires) will be completed by patient (WOMAC, UCLA, VR12, EQ5D, Oxford Hip).

Intervention type: OTHER
Intervention: Standard Post-Operative Clinic Visit
Description: In clinic, the joint will be assessed (ROM, stability testing), standard X-rays will be taken of the joint, and patient reported outcomes (questionnaires) will be completed by patient (WOMAC, UCLA, VR12, EQ5D, Oxford Hip).

Intervention type: OTHER
Intervention: Study-Specific Outcomes
Description: Patients will complete additional questionnaires (SF12 and HHS), will undergo RSA and CT imaging for implant stability analysis, and will provide a stool sample for gut microbiome analysis.

Intervention type: OTHER
Intervention: Study-Specific Outcomes
Description: Patients will complete additional questionnaires (SF12 and HHS), will undergo RSA and CT imaging for implant stability analysis, and will provide a stool sample for gut microbiome analysis.
Study: NCT05701163

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Abstinence followed by semen sample collection.
Description: Abstinence is the intervention. Semen samples will be collected after abstinence periods.
Study: NCT06672796

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Stretching exercise
Description: Toe stretching

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stretching exercise
Description: Toe stretching

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Stretching exercise
Description: Toe stretching
Study: NCT06672848

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Numeretic rating scale (NRS)
Description: NRS is a pain intensity determination system based on the person being asked to describe their pain on a scale of 0 (none), 10 (unbearable pain) and a point between.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Numeretic rating scale (NRS)
Description: NRS is a pain intensity determination system based on the person being asked to describe their pain on a scale of 0 (none), 10 (unbearable pain) and a point between.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Brief Pain Inventory (BPI)
Description: BPI is a chronic pain intensity determination system based on the person being asked to describe their pain on a scale of 0 (none), 10 (unbearable pain) and a point between.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Brief Pain Inventory (BPI)
Description: BPI is a chronic pain intensity determination system based on the person being asked to describe their pain on a scale of 0 (none), 10 (unbearable pain) and a point between.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: The S-LANSS Pain Score
Description: The Leeds assessment of neuropathic symptoms and signs (LANSS) Pain Scale is based on analysis of sensory description and bedside examination of sensory dysfunction, and provides immediate information in clinical settings. It was developed in two populations of chronic pain patients.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: The S-LANSS Pain Score
Description: The Leeds assessment of neuropathic symptoms and signs (LANSS) Pain Scale is based on analysis of sensory description and bedside examination of sensory dysfunction, and provides immediate information in clinical settings. It was developed in two populations of chronic pain patients.
Study: NCT00990301

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moexipril HCl/ Hydrochlorothiazide 15mg/ 25mg Tablet, Paddock Laboratories, Inc.
Description: test drug

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Moexipril HCl/ Hydrochlorothiazide 15mg/ 25mg Tablet, Paddock Laboratories, Inc.
Description: test drug
Study: NCT04561388

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Electrocochleography
Description: Electrocochleographic responses will be evoked using different pure tone sounds delivered through an insert placed in the external auditory duct. The responses will be recorded with the electrodes of the cochlear implant connected to a dedicated interface.~Electrocochleographic responses will be collected continuously during the electrode-array insertion at the implantation surgery using 500Hz pure tone and after suturing with 250, 500, 750 and 1000Hz pure tones. Then, electrocochleographic responses to pure tones from 125 to 8000HZ (according to the subject residual hearing) will be recorded 2 weeks, 1 month, 2 months and 4 months after implantation.
Study: NCT00990301

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Uniretic® 15mg/25mg Tablets
Description: reference drug
Study: NCT05641077

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Visit
Description: Patients randomized to this arm will be scheduled for and follow up with the surgeon or an advanced practice provider via a virtual visit using videoconference technology at 6 weeks after the anticipated date of surgery. If the surgery were to be rescheduled to a future date, the postoperative visit will be moved accordingly to ensure follow-up occurs at the 6-week postoperative period.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Office Visit
Description: Patients randomized to this arm will be scheduled for and follow up with the surgeon or an advanced practice provider via an in-office visit at 6 weeks after the planned date of surgery. If the surgery were to be rescheduled to a future date, the postoperative visit will be moved accordingly to ensure follow-up occurs at the 6-week postoperative period.
Study: NCT04561388

Intervention type: OTHER
Group type: OTHER
Intervention: Pure Tone Audiometry
Description: The perception thresholds to 125, 250, 500, 750, 1000, 2000, 4000 and 8000 Hz pure tones will be measured within the month preceding the implantation using the same insert t.~Pure tone audiometry with the same frequencies will be done 2 weeks, 1, 2 and 4 months after the implantation.

Intervention type: OTHER
Group type: OTHER
Intervention: Speech audiometry
Description: The speech perception will be assessed in silence and in noise in free field 1 and 4 months after implantation. The speech perception in silence will be assessed using monosyllabic words 60 dB SPL. Speech in noise will be assessed using an adaptative test with fixed noise level (60 dB SPL).
Study: NCT06673433

Intervention type: DIAGNOSTIC_TEST
Intervention: obesity
Description: Patients diagnosed with obesity (BMI ≥ 28kg/m2)

Intervention type: DIAGNOSTIC_TEST
Intervention: health
Description: the health control group include paticipants with nomal BMI
Study: NCT06672263

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQB3911 tablets
Description: TQB3911 is a small molecule BCR::ABL1 allosteric inhibitor. By occupying the myristyl binding site, TQB3911 recovers the inhibition of BCR::ABL1 fusion protein kinase activity, and ultimately inhibits the proliferation of tumor cells.
Study: NCT06673342

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nutritional Counseling
Description: Nutritional counseling based on Stephan's Curve. The Stephan's curve is a diagram that shows how the acidity of the oral cavity changes with consumption of food, specifically with added sugar. A laminated Stephan's curve will be used to show the drop of pH (acidity) based on the subject's reported daily consumption of food and snacks. Recommendations will be provided on a balanced diet according to the American Dental Association guidelines and recommendations on reducing the frequency of snacking.
Study: NCT06672432

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CareMom (a mobile app-based 8-wekk cognitive behavioral therapy program)
Description: The intervention is divided into daily tasks spread across eight weeks, with each day involving a variety of interactive elements such as videos, text-based content, guided reflections, and mental health check-ins. If the user misses a daily challenge, she can complete that challenge in the later days. Each week has a distinct focus that progressively builds the user's skills and understanding in managing emotional health. Tasks are designed to be short yet impactful, aiming to enhance engagement and adherence.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Matched Attention Control (a mobile app-based 8-week online relaxation training program)
Description: This program is designed to mirror the structure and engagement level of the intervention group, providing participants with a similar amount of interaction and daily activities. Each day, participants in the control group will complete 1-2 daily tasks focused on relaxation techniques, such as breathing exercises, mindfulness meditation, and guided imagery. Each task is brief, approximately 3 minutes in duration, making it easy for participants to incorporate into their daily routine.
Study: NCT06672887

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MiLES
Description: The MiLES intervention is an open access website, accessible via an URL, but not traceable through any online search engine during the study period. Tailored for specific preferences and needs of different employees with cancer, the MiLES intervention consists of interactive videos, conversation checklists, tips and information regarding RTW guidance of employees with cancer, and an overview of involved stakeholders and relevant legislation. The MiLES intervention intends to optimize the RTW support the employer provides to the employee with cancer by enhancing the willingness and ability to implement the employer actions. The MiLES intervention focuses for example on fostering effective communication between the employer and employee, while disregarding assumptions based on previous experiences.
Study: NCT05740007

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IW-3300 rectal foam
Description: IW-3300 rectal foam administered daily for 12 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IW-3300 rectal foam
Description: IW-3300 rectal foam administered daily for 12 weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo rectal foam administered daily for 12 weeks
Study: NCT04766502

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood sample (20 ml) and EORTC QLQC30 survey
Description: Blood sample (20ml) will be taken before and 24h after PIPAC procedure~EORTC QLQC30 during pre operative consultation and at each post operative consultations
Study: NCT05115461

Intervention type: DEVICE
Intervention: Biodex Balance System™ SD
Description: Postural stability index values (anteroposterior, mediolateral and overall) will be measured for static and dynamic conditions.
Study: NCT05062564

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LipiFlow Thermal pulsation system
Description: Single treatment with LipiFlow thermal pulsation system on the eyelids within two months before surgery

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Eyelid warm compresses plus massages
Description: Eyelid warm compresses plus massages twice a day for the preoperative month
Study: NCT05115461

Intervention type: DEVICE
Intervention: Biodex Balance System™ SD
Description: Postural stability index values (anteroposterior, mediolateral and overall) will be measured for static and dynamic conditions.

Intervention type: OTHER
Intervention: questionnaires and inventories
Description: questionnaires and inventories related to primary end secondary outcomes will be applied and physical examination will be performed.
Study: NCT06080347

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Anti-inflammatory Diet
Description: Dietary intervention

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Healthy Diet
Description: Dietary intervention
Study: NCT06673108

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: SoLa Pelvic Therapy
Description: SoLa Pelvic Therapy laser emits near-infrared (810-980 nm wavelength) energy to the vaginal tissues. The device treats at 5-8 W for 3-6 minutes and delivers a fluence of 3,000 and 5,000 J/cm2 through a sterile vaginal probe. Specific treatment time is calculated based on vaginal length. Based on a code input, the device can cycle between emitting laser energy or sham which is visible light without focused laser energy.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SoLa Pelvic Therapy
Description: SoLa Pelvic Therapy laser emits near-infrared (810-980 nm wavelength) energy to the vaginal tissues. The device treats at 5-8 W for 3-6 minutes and delivers a fluence of 3,000 and 5,000 J/cm2 through a sterile vaginal probe. Specific treatment time is calculated based on vaginal length. Based on a code input, the device can cycle between emitting laser energy or sham which is visible light without focused laser energy.
Study: NCT06672692

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: LIAISON NES FLU A/B, RSV & COVID-19
Description: The LIAISON® NES FLU A/B, RSV \& COVID-19 assay used on the LIAISON® NES instrument is a real-time PCR system that enables the direct amplification, detection and differentiation of Flu A viral RNA, Flu B viral RNA RSV viral RNA, and SARS-CoV-2 RNA from dry nasal swabs. Nasal Swabs can be professionally collected by a Healthcare Provider or self-collected by the patient under the supervision of the healthcare provider. The collected nasal swab can then be directly loaded into the cartridge without nucleic acid extraction.
Study: NCT06673394

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Complement protein C5 inhibitor
Description: Investigational arm: eculizumab (900 mg) will be administered intravenously once per week for a total of four doses (days 1, 8, 15, and 22) in conjunction with IVMP and oral prednisone (60mg, 5mg weekly decline). Terminal complement complex inhibition by eculizumab predisposes patients to infections by encapsulated bacteria, especially N meningitidis. Meningococcal vaccination will not be effective in this timeframe; instead, all enrolled patients will receive antibiotic prophylaxis against N meningitidis from the time of the first dose of the study drug to 8 weeks after the last administration.

Intervention type: DRUG
Group type: OTHER
Intervention: IVMP
Description: IVMP arm: 1000mg methylprednisolone x5d, oral prednisone 60mg, 5mg weekly decline + antibiotics

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: IVMP
Description: IVMP arm: 1000mg methylprednisolone x5d, oral prednisone 60mg, 5mg weekly decline + antibiotics
Study: NCT06672744

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: Lumbar muscles (especially quadratus lumborum) and thoracolumbar fascia stretching exercises and strengthening exercises for the lumbar and abdominal muscles were described by the physiotherapist. Participants were asked to perform the exercises three times a day, five days a week

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial release technique
Description: Myofascial release technique was applied by the same researcher (YY) twice a week for four weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesiotaping
Description: Kinesiotaping was performed by the same researcher (XX) for two sessions per week for four weeks with fascia correction technique
Study: NCT06672757

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CV_AID
Description: Upon arrival at the scene, the paramedic utilizes a mobile app with an integrated camera to aid in conducting the National Institutes of Health Stroke Scale (NIHSS) assessment. The app assists in scoring the patient\&#39;s responses according to NIHSS criteria to determine the severity of stroke symptoms.~If the app assessment indicates a high likelihood of stroke, transport can be initiated without a conference with the neurovascular centre. The app shares the recorded NIHSS assessment and video of the patient with the neurovascular centre for review.~While en route, the paramedic confer with the neurovascular centre to discuss the patient\&#39;s condition and determine appropriate course of action. If the neurovascular centre decides not to treat the patient, transport can be diverted to the nearest hospital.~The paramedic documents all assessment findings, interventions, and communications related to the stroke patient in the patient care record. U
Study: NCT05950048

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The web-based breastfeeding counseling
Description: To the web-based breastfeeding counseling/experimental group (n =33), during the first 6 months after birth, they will be directed to the web-based breastfeeding consultancy website. On this page, mothers will receive counseling on breastfeeding (written, visual, audio materials and telephone counseling) from birth. In addition, the Web-based breastfeeding counseling/experimental group will fill out data collection forms in the first 24 hours, 1st, 2nd, 4th and 6th months after delivery.
Study: NCT05898646

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: X-Ray Imaging
Description: Undergo x-ray imaging
Study: NCT06544863

Intervention type: OTHER
Intervention: Data collection and blood sample
Description: In addition to collecting medical data, additional blood samples will be collected in order to create a biological collection and identify biomarkers associated with the occurrence of cirrhosis-related complications, progression to TH and follow-up.
Study: NCT06619990

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: XmAb942
Description: Antibody
Study: NCT05898646

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study: NCT06249113

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: NaCl 0.9%
Description: NaCl 0.9% continous intravenous on tumor craniotomy surgery

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Adjuvant lidocaine continous
Description: Adjuvant lidocaine continous intravenous on tumor craniotomy surgery
Study: NCT06002074

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stress Management and Resilience Training Program
Description: One-on-one stress management and resilience consultation by a certified SMART trainer followed by self-guided on-line training consisting of 4 modules.